아시아태평양의 측방 유동 어세이 시장 : 예측과 지역별 분석 - 제품 유형별, 수법별, 검사 유형별, 용도별, 최종 사용자별(-2030년)

The Asia Pacific lateral flow assay market was valued at US$ 1,271.23 million in 2022 and is expected to reach US$ 2,636.19 million by 2030; it is estimated to register a CAGR of 9.5% from 2022 to 2030.

Evolving Applications of Lateral Flow Assays Boost Asia Pacific Lateral Flow Assay Market

Lateral flow assays are widely used for infectious disease diagnosis, heart disease diagnosis, and veterinary applications. However, the scope of their applications has expanded in recent years. Behavioral health, saliva-based diagnostics, biological warfare (detection of Bacillus anthracis), environmental testing (detection of contaminating enzymes in production facilities), agriculture (detection of genetically modified organisms and quality control of plants), food microbiology (Detection of E. coli O157, Salmonella, Listeria, and other food spoilage bacteria) have emerged as new application areas for lateral flow assays.

Atlas-Link Biotech (Beijing) provides FASPIT Antigen Saliva Test Kit. NOVA Test SARS-CoV-2 Antigen Saliva Test Kit (Colloidal Gold Immunochromatography) is a lateral flow assay that uses the double-antibody sandwich method to detect the SARS-CoV-2 nucleocapsid protein from saliva specimens from patients who are suspected of SARS-CoV-2 by a healthcare provider. Only certified laboratories that meet the requirements for performing moderate, high, or waived complexity tests can perform such saliva-based tests. The SARS-CoV-2 antigen saliva test kits provide preliminary test results, with negative results that don't preclude SARS-CoV-2 infection.

Asia Pacific Lateral Flow Assay Market Overview

Asia Pacific (APAC) lateral flow assay market is segmented into Australia, China, India, Japan, South Korea, and the Rest of Asia. Countries such as China, Japan, and India are expected to be among the largest contributors to the Asia lateral flow assay market due to rising noncommunicable diseases and increasing market developments. Additionally, the region holds huge potential for the lateral flow assay market players to grow during the forecast period.

China is a developing country in Asia Pacific with a well-established healthcare system and a fast-growing pharmaceutical industry. China is home to various medical, pharmaceutical, and biotechnology product manufacturing companies operating in the global market. These pharmaceutical and biotechnology companies are involved in developing various testing kits and devices for infections and diseases.

Asia Pacific Lateral Flow Assay Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific Lateral Flow Assay Market Segmentation

The Asia Pacific lateral flow assay market is categorized into product type, technique, test type, application, end user, and country.

Based on product type, the Asia Pacific lateral flow assay market is bifurcated into kits & reagents and lateral flow readers. The kits & reagents segment held a larger Asia Pacific lateral flow assay market share in 2022.

In terms of technique, the Asia Pacific lateral flow assay market is segmented into sandwich assay, competitive assays, and multiplex detection assay. The sandwich assay segment held the largest Asia Pacific lateral flow assay market share in 2022.

By test type, the Asia Pacific lateral flow assay market is divided into lateral flow immunoassay and nucleic acid lateral flow assay. The lateral flow immunoassay segment held a larger Asia Pacific lateral flow assay market share in 2022.

Based on application, the Asia Pacific lateral flow assay market is categorized into clinical testing, veterinary diagnostics, food safety & environment testing, and drug development & quality testing. The clinical testing segment held the largest Asia Pacific lateral flow assay market share in 2022.

By end user, the Asia Pacific lateral flow assay market is segmented into hospitals and clinics, diagnostics laboratories, homecare, veterinary clinics, pharmaceutical & biotechnology companies, and others. The hospitals and clinics segment held the largest Asia Pacific lateral flow assay market share in 2022.

By country, the Asia Pacific lateral flow assay market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific lateral flow assay market share in 2022.

F. Hoffmann-La Roche Ltd, Siemens Healthineers AG, Becton Dickinson and Co, PerkinElmer Inc, Hologic Inc, QIAGEN NV, bioMerieux SA, QuidelOrtho Corp, Abbott Laboratories, Merck KGaA, Bio-Rad Laboratories Inc, and Thermo Fisher Scientific Inc are some of the leading companies operating in the Asia Pacific lateral flow assay market.

Table Of Contents

1. Introduction

• 1.1 The Insight Partners Research Report Guidance
• 1.2 Market Segmentation

2. Executive Summary

• 2.1 Key Insights

3. Research Methodology

• 3.1 Coverage
• 3.2 Secondary Research
• 3.3 Primary Research

4. Asia Pacific Lateral Flow Assay Market - Key Industry Dynamics

• 4.1 Asia Pacific Lateral Flow Assay Market - Key Industry Dynamics
• 4.2 Market Drivers
  • 4.2.1 Increasing Use of Home-Based Assay Kits
  • 4.2.2 Rising Popularity of Point-of-Care Testing
• 4.3 Market Restraints
  • 4.3.1 Inconsistent Assay Results Due to Procedural Limitations
• 4.4 Market Opportunities
  • 4.4.1 Evolving Applications of Lateral Flow Assays
• 4.5 Future Trends
  • 4.5.1 Smartphone Usage and AI Integration in Lateral Flow Immunoassay
• 4.6 Impact analysis

5. Lateral Flow Assay Market - Asia Pacific Market Analysis

• 5.1 Asia Pacific Lateral Flow Assay Market Revenue (US$ Mn), 2020 - 2030

6. Asia Pacific Lateral Flow Assay Market Analysis - Product Type

• 6.1 Kits & Reagents
  • 6.1.1 Overview
  • 6.1.2 Kits & Reagents: Asia Pacific Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)
• 6.2 Lateral Flow Readers
  • 6.2.1 Overview
  • 6.2.2 Lateral Flow Readers: Asia Pacific Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)

7. Asia Pacific Lateral Flow Assay Market Analysis - Technique

• 7.1 Sandwich Assay
  • 7.1.1 Overview
  • 7.1.2 Sandwich Assay: Asia Pacific Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)
• 7.2 Competitive Assays
  • 7.2.1 Overview
  • 7.2.2 Competitive Assays: Asia Pacific Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)
• 7.3 Multiplex Detection Assay
  • 7.3.1 Overview
  • 7.3.2 Multiplex Detection Assay: Asia Pacific Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)

8. Asia Pacific Lateral Flow Assay Market Analysis - Test Type

• 8.1 Lateral Flow Immunoassay
  • 8.1.1 Overview
  • 8.1.2 Lateral Flow Immunoassay: Asia Pacific Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)
• 8.2 Nucleic Acid Lateral Flow Assay
  • 8.2.1 Overview
  • 8.2.2 Nucleic Acid Lateral Flow Assay: Asia Pacific Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)

9. Asia Pacific Lateral Flow Assay Market Analysis - Application

• 9.1 Clinical Testing
  • 9.1.1 Overview
  • 9.1.2 Clinical Testing: Asia Pacific Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)
• 9.2 Veterinary Diagnostics
  • 9.2.1 Overview
  • 9.2.2 Veterinary Diagnostics: Asia Pacific Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)
• 9.3 Food Safety & Environment Testing
  • 9.3.1 Overview
  • 9.3.2 Food Safety & Environment Testing: Asia Pacific Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)
• 9.4 Drug Development & Quality Testing
  • 9.4.1 Overview
  • 9.4.2 Drug Development & Quality Testing: Asia Pacific Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)

10. Asia Pacific Lateral Flow Assay Market Analysis - End User

• 10.1 Hospitals and Clinics
  • 10.1.1 Overview
  • 10.1.2 Hospitals and Clinics: Asia Pacific Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)
• 10.2 Diagnostics Laboratories
  • 10.2.1 Overview
  • 10.2.2 Diagnostics Laboratories: Asia Pacific Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)
• 10.3 Homecare
  • 10.3.1 Overview
  • 10.3.2 Homecare: Asia Pacific Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)
• 10.4 Veterinary Clinics
  • 10.4.1 Overview
  • 10.4.2 Veterinary Clinics: Asia Pacific Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)
• 10.5 Pharmaceutical & Biotechnology Companies
  • 10.5.1 Overview
  • 10.5.2 Pharmaceutical & Biotechnology Companies: Asia Pacific Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)
• 10.6 Others
  • 10.6.1 Overview
  • 10.6.2 Others: Asia Pacific Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)

11. Asia Pacific Lateral Flow Assay Market - Country Analysis

• 11.1 Asia Pacific Lateral Flow Assay Market, Revenue and Forecast to 2030
  • 11.1.1 Asia Pacific Lateral Flow Assay Market Revenue and Forecasts and Analysis - By Country
    • 11.1.1.1 China: Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Mn)
      • 11.1.1.1.1 Overview
      • 11.1.1.1.2 China Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Mn)
      • 11.1.1.1.3 China Lateral Flow Assay Market, by Product Type, 2020-2030 (US$ Million)
      • 11.1.1.1.4 China Lateral Flow Assay Market, by Technique, 2020-2030 (US$ Million)
      • 11.1.1.1.5 China Lateral Flow Assay Market, by Test Type, 2020-2030 (US$ Million)
      • 11.1.1.1.6 China Lateral Flow Assay Market, by Application, 2020-2030 (US$ Million)
      • 11.1.1.1.7 China Lateral Flow Assay Market, by End User, 2020-2030 (US$ Million)
    • 11.1.1.2 Japan: Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Mn)
      • 11.1.1.2.1 Overview
      • 11.1.1.2.2 Japan Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Mn)
      • 11.1.1.2.3 Japan Lateral Flow Assay Market, by Product Type, 2020-2030 (US$ Million)
      • 11.1.1.2.4 Japan Lateral Flow Assay Market, by Technique, 2020-2030 (US$ Million)
      • 11.1.1.2.5 Japan Lateral Flow Assay Market, by Test Type, 2020-2030 (US$ Million)
      • 11.1.1.2.6 Japan Lateral Flow Assay Market, by Application, 2020-2030 (US$ Million)
      • 11.1.1.2.7 Japan Lateral Flow Assay Market, by End User, 2020-2030 (US$ Million)
    • 11.1.1.3 India: Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Mn)
      • 11.1.1.3.1 Overview
      • 11.1.1.3.2 India Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Mn)
      • 11.1.1.3.3 India Lateral Flow Assay Market, by Product Type, 2020-2030 (US$ Million)
      • 11.1.1.3.4 India Lateral Flow Assay Market, by Technique, 2020-2030 (US$ Million)
      • 11.1.1.3.5 India Lateral Flow Assay Market, by Test Type, 2020-2030 (US$ Million)
      • 11.1.1.3.6 India Lateral Flow Assay Market, by Application, 2020-2030 (US$ Million)
      • 11.1.1.3.7 India Lateral Flow Assay Market, by End User, 2020-2030 (US$ Million)
    • 11.1.1.4 South Korea: Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Mn)
      • 11.1.1.4.1 Overview
      • 11.1.1.4.2 South Korea Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Mn)
      • 11.1.1.4.3 South Korea Lateral Flow Assay Market, by Product Type, 2020-2030 (US$ Million)
      • 11.1.1.4.4 South Korea Lateral Flow Assay Market, by Technique, 2020-2030 (US$ Million)
      • 11.1.1.4.5 South Korea Lateral Flow Assay Market, by Test Type, 2020-2030 (US$ Million)
      • 11.1.1.4.6 South Korea Lateral Flow Assay Market, by Application, 2020-2030 (US$ Million)
      • 11.1.1.4.7 South Korea Lateral Flow Assay Market, by End User, 2020-2030 (US$ Million)
    • 11.1.1.5 Australia: Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Mn)
      • 11.1.1.5.1 Overview
      • 11.1.1.5.2 Australia Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Mn)
      • 11.1.1.5.3 Australia Lateral Flow Assay Market, by Product Type, 2020-2030 (US$ Million)
      • 11.1.1.5.4 Australia Lateral Flow Assay Market, by Technique, 2020-2030 (US$ Million)
      • 11.1.1.5.5 Australia Lateral Flow Assay Market, by Test Type, 2020-2030 (US$ Million)
      • 11.1.1.5.6 Australia Lateral Flow Assay Market, by Application, 2020-2030 (US$ Million)
      • 11.1.1.5.7 Australia Lateral Flow Assay Market, by End User, 2020-2030 (US$ Million)
    • 11.1.1.6 Rest of Asia Pacific: Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Mn)
      • 11.1.1.6.1 Overview
      • 11.1.1.6.2 Rest of APAC Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Mn)
      • 11.1.1.6.3 Rest of APAC Lateral Flow Assay Market, by Product Type, 2020-2030 (US$ Million)
      • 11.1.1.6.4 Rest of APAC Lateral Flow Assay Market, by Technique, 2020-2030 (US$ Million)
      • 11.1.1.6.5 Rest of APAC Lateral Flow Assay Market, by Test Type, 2020-2030 (US$ Million)
      • 11.1.1.6.6 Rest of APAC Lateral Flow Assay Market, by Application, 2020-2030 (US$ Million)
      • 11.1.1.6.7 Rest of APAC Lateral Flow Assay Market, by End User, 2020-2030 (US$ Million)

12. Industry Landscape

• 12.1 Overview
• 12.2 Growth Strategies in the Lateral Flow Assay Market
• 12.3 Organic Growth Strategies
  • 12.3.1 Overview
• 12.4 Inorganic Growth Strategies
  • 12.4.1 Overview

13. Company Profiles

• 13.1 F. Hoffmann-La Roche Ltd
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
• 13.2 Siemens Healthineers AG
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
• 13.3 Becton Dickinson and Co
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
• 13.4 PerkinElmer Inc
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
• 13.5 Hologic Inc
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
• 13.6 QIAGEN NV
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
• 13.7 bioMerieux SA
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
• 13.8 QuidelOrtho Corp
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
• 13.9 Abbott Laboratories
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments
• 13.10 Merck KGaA
  • 13.10.1 Key Facts
  • 13.10.2 Business Description
  • 13.10.3 Products and Services
  • 13.10.4 Financial Overview
  • 13.10.5 SWOT Analysis
  • 13.10.6 Key Developments
• 13.11 Bio-Rad Laboratories Inc
  • 13.11.1 Key Facts
  • 13.11.2 Business Description
  • 13.11.3 Products and Services
  • 13.11.4 Financial Overview
  • 13.11.5 SWOT Analysis
  • 13.11.6 Key Developments
• 13.12 Thermo Fisher Scientific Inc
  • 13.12.1 Key Facts
  • 13.12.2 Business Description
  • 13.12.3 Products and Services
  • 13.12.4 Financial Overview
  • 13.12.5 SWOT Analysis
  • 13.12.6 Key Developments

14. Appendix

• 14.1 About The Insight Partners
• 14.2 Glossary of Terms